Fractal Investments LLC Acquires New Shares in Nutrien Ltd. (NYSE:NTR)

Fractal Investments LLC purchased a new stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,700 shares of the company's stock, valued at approximately $333,000.

Several other large investors have also recently bought and sold shares of the stock. Allworth Financial LP raised its stake in Nutrien by 117.1% in the first quarter. Allworth Financial LP now owns 938 shares of the company's stock valued at $50,000 after buying an additional 506 shares during the period. GAMMA Investing LLC raised its stake in Nutrien by 4,866.7% in the first quarter. GAMMA Investing LLC now owns 1,043 shares of the company's stock valued at $52,000 after buying an additional 1,022 shares during the period. Summit Securities Group LLC raised its stake in Nutrien by 225.0% in the fourth quarter. Summit Securities Group LLC now owns 1,300 shares of the company's stock valued at $58,000 after buying an additional 900 shares during the period. HM Payson & Co. bought a new stake in Nutrien in the first quarter valued at approximately $65,000. Finally, Bessemer Group Inc. raised its stake in Nutrien by 163.7% in the first quarter. Bessemer Group Inc. now owns 1,690 shares of the company's stock valued at $84,000 after buying an additional 1,049 shares during the period. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Price Performance

Shares of NTR stock traded down $0.34 during trading hours on Friday, reaching $59.95. The company's stock had a trading volume of 364,236 shares, compared to its average volume of 2,284,229. The company has a quick ratio of 0.59, a current ratio of 1.22 and a debt-to-equity ratio of 0.41. Nutrien Ltd. has a fifty-two week low of $43.69 and a fifty-two week high of $65.08. The company has a market capitalization of $29.20 billion, a price-to-earnings ratio of 56.03, a PEG ratio of 1.12 and a beta of 0.80. The firm's 50 day simple moving average is $60.00 and its 200-day simple moving average is $54.73.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.24). Nutrien had a net margin of 2.05% and a return on equity of 6.08%. The firm had revenue of $4.67 billion for the quarter, compared to analyst estimates of $5.16 billion. During the same period last year, the business earned $0.46 EPS. The company's revenue was down 5.4% compared to the same quarter last year. Sell-side analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current year.

Nutrien Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 18th. Investors of record on Monday, June 30th were issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 3.64%. The ex-dividend date was Monday, June 30th. Nutrien's dividend payout ratio (DPR) is 203.74%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on NTR. Scotiabank lowered Nutrien from an "outperform" rating to a "sector perform" rating and set a $62.00 price objective on the stock. in a research note on Thursday, May 22nd. Barclays upped their price objective on Nutrien from $61.00 to $64.00 and gave the company an "equal weight" rating in a research note on Monday, July 7th. Oppenheimer upped their price objective on Nutrien from $63.00 to $65.00 and gave the company an "outperform" rating in a research note on Tuesday, July 15th. TD Securities increased their target price on Nutrien from $64.00 to $67.00 and gave the stock a "buy" rating in a research note on Monday, May 12th. Finally, The Goldman Sachs Group increased their target price on Nutrien from $53.00 to $59.00 and gave the stock a "sell" rating in a research note on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $63.22.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.